Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...

This writer digs into the CRISPR gene-editing space, asking whether one particular penny stock is worth taking a punt on in his ISA.

No adverse objective or subjective events were noted with the use of the reinfusion drains. No patients had temperature elevations exceeding 38.1°C (100.6°F) in the first 2 days postoperatively ...

According to latest report, the U.S. cell and gene therapy CDMO market size was valued at USD 3.19 billion in 2024 and is projected to hit around USD 33.24 billion by 2034, growing at a compound ...

SWECARNET collects information direct from treating clinicians to map the use of CAR T in Sweden. The first CAR T to be manufactured in Sweden (and Europe) was in 2014 at Vecura, Stockholm, and was ...